Abstract: Globally, Campylobacters have been reported as leading cause of gastroenteritis in man as well as animals and considered as emerging zoonotic problem particularly in developing countries including India. A cross-sectional study was conducted to know the prevalence and epidemiological determinants for Campylobacter spp. in dogs in and around Mathura city, Uttar Pradesh, India. Based on isolation, cultural and biochemical characterization of bacteria, the prevalence of Campylobacter spp. was 34.24%. Younger dogs (less than 1 year of age) were more likely to carry Campylobacter spp. High prevalence of Campylobacter spp. supports the hypothesis that dogs, particularly younger animals, may be an important source of Campylobacter infection for humans. Breed-wise prevalence showed that non-descript dogs (45.97%) were more likely to carry Campylobacter infections. Dogs showing clinical signs of gastroenteritis were showing higher prevalence (47.21%) in comparison to that of animals without gastro-intestinal disorders (15.04%). Out of 113 Campylobacter isolates of canine origin, two isolates were resistant to all the nineteen antibiotics used in the study, while all the isolates were resistant to Streptomycin, Ampicillin, Amoxycillin, Aztreonam, Lincomycin, Tetracyclin, Oxytetracyclin and Penicillin. A high rate of resistance was observed to Cefotaxim (97.35%), Peefloxacin (91.15%), Chloramphenicol (90.27%), Ofloxacin (84.07%), Ciprofloxacin (83.18%), Cefaclor (80.53%), Nitrofurazone (76.11%), Norfloxacin (74.33%), Gentamicin (42.48%), Amikacin (40.71%) and Enrofloxacin (36.28%). Our results indicate Amikacin and Gentamicin as drugs suitable for the treatment of campylobacteriosis in dogs.